Article Details
Retrieved on: 2022-04-27 17:01:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Zentalis and Pfizer plan to jointly advance the clinical development of ZN-c3, a selective Wee1 inhibitor designed to induce synthetic lethality ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here